Literature DB >> 21660760

High specificity of the Word Memory Test and Medical Symptom Validity Test in groups with severe verbal memory impairment.

Paul Green1, Jorge Montijo, Robbi Brockhaus.   

Abstract

By definition, false positives occur when an otherwise very easy symptom validity test (SVT) or effort test is failed because of cognitive impairment and not because of poor effort. Therefore, the highest rate of false positives will be found in those groups with the most severe cognitive impairment. For that reason, it is important to study people with severe impairment when evaluating the specificity of SVTs. Some people with various types of dementia, notably those with Alzheimer's disease, suffer from severe impairment of memory and other cognitive abilities. In this study, patients with possible or probable dementia were tested with the Word Memory Test (WMT; Green, 2003; Green & Astner, 1995) and the Medical Symptom Validity Test (MSVT; Green, 2004). While some dementia patients failed the easy subtests of these instruments and had severe verbal memory impairment, they showed distinctive profiles of scores that have been reported to be characteristic of people with severe impairment. Using profile analysis, the WMT and MSVT achieved a specificity of 98.4% or higher in the patients of the current study. This suggests that there will be extremely low false positive rates using the same methods in people with relatively minor impairment of the type found in, for example, mild traumatic brain injury or depression.

Entities:  

Mesh:

Year:  2011        PMID: 21660760     DOI: 10.1080/09084282.2010.523389

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  8 in total

1.  Warfare exposure in later life and cognitive function: The moderating role of social connectedness.

Authors:  Ella Schwartz; Howard Litwin
Journal:  Psychiatry Res       Date:  2019-06-18       Impact factor: 3.222

2.  Effort in college undergraduates is sufficient on the word memory test.

Authors:  Octavio A Santos; Dmitriy Kazakov; Mary K Reamer; Sydney E Park; David C Osmon
Journal:  Arch Clin Neuropsychol       Date:  2014-08-22       Impact factor: 2.813

3.  A Meta-Analysis of Neuropsychological Effort Test Performance in Psychotic Disorders.

Authors:  Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Gregory P Strauss
Journal:  Neuropsychol Rev       Date:  2020-08-07       Impact factor: 7.444

4.  [Response distortion or symptom severity? Symptom description by psychiatric patients and sociomedical assessment subjects].

Authors:  Maximilian Wertz; Eva Mader; Norbert Nedopil; Kolja Schiltz; Elena Yundina
Journal:  Nervenarzt       Date:  2020-12-18       Impact factor: 1.214

5.  Clinical features of dementia cases ascertained by ICD coding in LIMBIC-CENC multicenter study of mild traumatic brain injury.

Authors:  William C Walker; Justin O'Rourke; Elisabeth Anne Wilde; Mary Jo Pugh; Kimbra Kenney; Clara Libby Dismuke-Greer; Zhining Ou; Angela P Presson; J Kent Werner; Jacob Kean; Deborah Barnes; Amol Karmarkar; Kristine Yaffe; David Cifu
Journal:  Brain Inj       Date:  2022-02-02       Impact factor: 2.167

6.  Investigation into repetitive concussion in sport (RECOS): study protocol of a prospective, exploratory, observational cohort study.

Authors:  Kamal M Yakoub; David J Davies; Zhangjie Su; Conor Bentley; Mario Forcione; Emma Toman; Douglas Hammond; Callum N Watson; Jon Bishop; Lauren Cooper; Aron K Barbey; Vijay Sawlani; Valentina Di Pietro; Michael J Grey; Antonio Belli
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

Review 7.  Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.

Authors:  Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson
Journal:  Curr Psychiatry Rep       Date:  2021-07-13       Impact factor: 8.081

Review 8.  Effort, symptom validity testing, performance validity testing and traumatic brain injury.

Authors:  Erin D Bigler
Journal:  Brain Inj       Date:  2014-09-12       Impact factor: 2.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.